ADMA - ADMA Biologics Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call Transcript

ADMA Biologics, Inc. (ADMA) Q1 2022 Earnings Conference Call May 11, 2022 4:30 P.M. ET Company Participants Skyler Bloom - Senior Director, Business Development and Corporate Strategy Adam Grossman - President and Chief Executive Officer Brian Lenz - Executive Vice President, Chief Financial Officer and General Manager, ADMA BioCenters Conference Call Participants Elliot Wilbur - Raymond James Kristen Kluska - Cantor Fitzgerald Presentation Operator Good afternoon, and welcome to the ADMA Biologics First Quarter 2022 Financial Results and Corporate Update Conference Call on Wednesday, May 11, 2022. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately two hours following the end of the call. At this time, I like to introduce Skyler Bloom, Senior Director of Business Development and Corporate Strategy at ADMA Biologics. Please

For further details see:

ADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call Transcript